Oligosaccharides increase the genotoxic effect of colibactin produced by pks+ Escherichia coli strains
Open Access
- 17 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 21 (1), 1-10
- https://doi.org/10.1186/s12885-021-07876-8
Abstract
Colibactin is a genotoxin that induces DNA double-strand breaks that may lead to carcinogenesis and is produced by Escherichia coli strains harboring the pks island. Human and animal studies have shown that colibactin-producing gut bacteria promote carcinogenesis and enhance the progression of colorectal cancer through cellular senescence and chromosomal abnormalities. In this study, we investigated the impact of prebiotics on the genotoxicity of colibactin-producing E. coli strains Nissle 1917 and NC101. Bacteria were grown in medium supplemented with 20, 30 and 40 mg/mL of prebiotics inulin or galacto-oligosaccharide, and with or without 5 μM, 25 μM and 125 μM of ferrous sulfate. Colibactin expression was assessed by luciferase reporter assay for the clbA gene, essential for colibactin production, in E. coli Nissle 1917 and by RT-PCR in E. coli NC101. The human epithelial colorectal adenocarcinoma cell line, Caco-2, was used to assess colibactin-induced megalocytosis by methylene blue binding assay and genotoxicity by γ-H2AX immunofluorescence analysis. Inulin and galacto-oligosaccharide enhanced the expression of clbA in pks+ E. coli. However, the addition of 125 μM of ferrous sulfate inhibited the expression of clbA triggered by oligosaccharides. In the presence of either oligosaccharide, E. coli NC101 increased dysplasia and DNA double-strand breaks in Caco-2 cells compared to untreated cells. Our results suggest that, in vitro, prebiotic oligosaccharides exacerbate DNA damage induced by colibactin-producing bacteria. Further studies are necessary to establish whether oligosaccharide supplementation may lead to increased colorectal tumorigenesis in animal models colonized with pks+ E. coli.Keywords
Funding Information
- Canadian Institutes of Health Research (PJT-159775)
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2018-06442)
- Institut Du Cancer de Montréal (scholarship)
- Université de Montréal (scholarship)
- Fonds de Recherche du Québec - Santé (MSSS Resident Physician Health Research Career Training Program)
- Interdisciplinary Center for Clinical Research of the Medical Faculty Münster (Dob2/013/12)
This publication has 53 references indexed in Scilit:
- Escherichia coli Producing Colibactin Triggers Premature and Transmissible Senescence in Mammalian CellsPLOS ONE, 2013
- Interplay between Siderophores and Colibactin Genotoxin Biosynthetic Pathways in Escherichia coliPLoS Pathogens, 2013
- High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon CancerPLOS ONE, 2013
- Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activityGut Microbes, 2012
- Intestinal Inflammation Targets Cancer-Inducing Activity of the MicrobiotaScience, 2012
- Inulin results in increased levels of β-catenin and cyclin D1 as the adenomas increase in size from small to large in the Min/+ mouseBritish Journal of Nutrition, 2008
- Expression analysis of the colibactin gene cluster coding for a novel polyketide inEscherichia coliFEMS Microbiology Letters, 2007
- Prebiotic Galactooligosaccharides Reduce Adherence of EnteropathogenicEscherichia colito Tissue Culture CellsInfection and Immunity, 2006
- Promotion of intestinal tumor formation by inulin is associated with an accumulation of cytosolic β-catenin in Min miceInternational Journal of Cancer, 2003
- In vitro investigations of the effect of probiotics and prebiotics on selected human intestinal pathogensFEMS Microbiology Ecology, 2002